R. Mayol

发表

In vitro metabolism of the antianxiety drug buspirone as a predictor of its metabolism in vivo.

I. Blair, H. K. Jajoo, L. Klunk, 1990, Xenobiotica; the fate of foreign compounds in biological systems.

Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics.

D. Roden, J. Oates, R. Woosley, 1980, The New England journal of medicine.

Direction of Translation and Size of Bacteriophage φX174 Cistrons

R. Benbow, R. Mayol, R. Sinsheimer, 1972, Journal of virology.

Studies on the synthesis of estrogen-specific uterine proteins. Comparison of methods of quantitative evaluation of double-isotope peaks

R. Mayol, 1975, Molecular and Cellular Endocrinology.

Metabolism of the antianxiety drug buspirone in human subjects.

I. Blair, H. K. Jajoo, R. Mayol, 1989, Drug metabolism and disposition: the biological fate of chemicals.

Isolation and identification of the major urinary metabolite of m-chlorophenylpiperazine in the rat.

C. Cole, E. Kerns, R. Mayol, 1994, Drug metabolism and disposition: the biological fate of chemicals.

Structural characterization of urinary metabolites of the antiarrhythmic drug encainide in human subjects.

I. Blair, H. K. Jajoo, R. Mayol, 1990, Drug metabolism and disposition: the biological fate of chemicals.

Metabolism and disposition of buspirone.

R. Mayol, J. A. Labudde, R. Gammans, 1986, The American journal of medicine.

The relationship between buspirone bioavailability and dose in healthy subjects.

R. Mayol, R. Gammans, A. Mackenthun, 1985, Biopharmaceutics & drug disposition.

Separation of Non-Sperm Components from Seminal Preparations and Their Effect on the Analysis of Sperm Proteins

R. Mayol, D. Longenecker, 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Process of infection with bacteriophage phiX174. XXXVI. Measurement of virus-specific proteins during a normal cycle of infection.

R. Mayol, R. Sinsheimer, 1970, Journal of virology.

Synthesis of estrogen-specific proteins in the uterus of the immature rat.

R. Mayol, S. Thayer, 1970, Biochemistry.

Development of a radioimmunoassay for blastokinin.

R. Mayol, D. Longenecker, 1974, Endocrinology.

Biopharmaceutical evaluation of transnasal, sublingual, and buccal disk dosage forms of butorphanol

M. Pfeffer, K. Pittman, R. Mayol, 1993, Biopharmaceutics & drug disposition.

Serum levels of butorphanol by radioimmunoassay.

K. Pittman, R. Mayol, R. D. Smyth, 1980, Journal of pharmaceutical sciences.

Analysis of Encainide in Plasma by Radioimmunoassay and High Pressure Liquid Chromatography

R. Mayol, R. Gammans, 1979 .

Total Suppression of Ventricular Arrhythmias by Encainide: Pharmacokinetic and Electrocardiographic Characteristics

D. Roden, J. Oates, R. Woosley, 1981 .

Pharmacokinetics of Buspirone in Elderly Subjects

J. P. Shea, R. Mayol, J. A. Labudde, 1989, Journal of clinical pharmacology.

Buspirone pharmacokinetics in patients with cirrhosis.

H. Poulsen, P. Garred, K. Dalhoff, 1987, British journal of clinical pharmacology.

Clinical Pharmacokinetics of Oral Buspirone in Patients with Impaired Renal Function

S. Garattini, S. Caccia, R. Mayol, 1988, Clinical pharmacokinetics.

Resolution of enantiomers of the antiarrhythmic drug encainide and its major metabolites by chiral derivatization and high-performance liquid chromatography.

C. Prakash, I. Blair, R. Mayol, 1989, Journal of chromatography.

Comparative effects of trazodone and tricyclic antidepressants on uptake of selected neurotransmitters by isolated rat brain synaptosomes

R. Mayol, L. Riblet, C. Gatewood, 1979, Psychopharmacology.

Liquid chromatography/chemical reaction interface mass spectrometry as an alternative to radioisotopes for quantitative drug metabolism studies.

I. Blair, L. Klunk, R. Mayol, 1996, Analytical chemistry.

Characterization of in vitro metabolites of the antipsychotic drug tiospirone by mass spectrometry.

I. Blair, L. Klunk, R. Mayol, 1990, Biomedical & environmental mass spectrometry.

Metabolism of the antianxiety drug buspirone in the rat.

I. Blair, R. Mayol, J. A. Labudde, 1989, Drug metabolism and disposition: the biological fate of chemicals.

Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.

C. Cole, E. Kerns, R. Mayol, 1994, Drug metabolism and disposition: the biological fate of chemicals.

Safety, Tolerance, and Preliminary Pharmacokinetics of Nefazodone After Administration of Single and Multiple Oral Doses to Healthy Adult Male Volunteers: A Double‐Blind, Phase I Study

P. Marathe, K. Pittman, R. Mayol, 1995, Journal of clinical pharmacology.

Pharmacologic study of oral ftorafur: Potential for improved oral delivery of 5-fluorouracil

R. Diasio, R. Mayol, J. A. Labudde, 1979 .

Comparative antiarrhythmic actions of encainide and its major metabolites.

R. Mayol, A. Gomoll, J. E. Byrne, 1986, Archives internationales de pharmacodynamie et de therapie.

Ia antigens on murine thymocytes: detection by cellular radioimmunoassay.

R. Mayol, N. Klinman, W. Elkins, 1977, Journal of immunology.